On October 9, 2026, TuHURA Biosciences drew an additional $650,000 from its existing revolving credit facility with Parkview Holdings One LLC. The loan agreement, originally entered into on April 21, 2026, provides for a maximum availability of $50 million and matures on April 21, 2031. The company intends to use the proceeds for general corporate purposes. TuHURA Biosciences operates in the biotechnology industry, focusing on drug discovery and development.
